Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets

Author:

Le Thao D.V.,Fathi Payam,Watters Amanda B.,Ellis Blair J.,Besing Gai-Linn K.,Bozadjieva-Kramer Nadejda,Perez Misty B.,Sullivan Andrew I.,Rose Jesse P.,Baggio Laurie L.,Koehler Jacqueline,Brown Jennifer L.,Bales Michelle B.,Nwaba Kaitlyn G.,Campbell Jonathan E.,Drucker Daniel J.,Potthoff Matthew J.,Seeley Randy J.,Ayala Julio E.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference96 articles.

1. Prevalence of overweight, obesity, and extreme obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018;Fryar;NCHS Health E-Stats,2020

2. National Health and Nutrition Examination Survey 2017–March 2020 prepandemic data files development of files and prevalence estimates for selected health outcomes;Stierman;National Health Stat Rep,2021

3. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study;Astrup;Lancet,2009

4. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials;Vilsbøll;BMJ,2012

5. A randomized, controlled trial of 3.0 mg of liraglutide in weight management;Pi-Sunyer;N Engl J Med,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3